Antiviral heteroaryl ketone derivatives
Grant
US12577240B2
Kind: B2
Mar 17, 2026
Assignee
Pfizer Inc.
Inventors
Dafydd Rhys Owen, Martin Youngjin Pettersson, Matthew Richard Reese, Matthew Forrest Sammons, Jamison Bryce Tuttle, Qingyi Yang
Abstract
The invention relates to compounds of Formula I wherein R1, R2, p, m, A, Z1, Z2, Z3 and Z4 are as defined herein, pharmaceutical compositions comprising the compounds, methods of treating COVID-19 in a patient by administering therapeutically effective amounts of the compounds, and methods of inhibiting or preventing replication of SARS-CoV-2 with the compounds.
CPC Classifications
C07D 417/14
A61P 31/14
Filing Date
2021-07-07
Application No.
18004996
Claims
27